Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR0465)
Drug Name
Dexchlorpheniramine maleate
Synonyms
Dexchloropheniramine maleate; Dexchlorpheniramine (maleate); Dexchlorpheniramine maleate; Dexchlorpheniramine maleate (USP); Dexchlorpheniramine maleate [USP]; Dextrochlorpheniramine maleate; EINECS 219-450-6; MFCD00079046; S-(+)-Chlorpheniramine maleate; S-(+)-Chlorpheniramine maleate salt; UNII-B10YD955QW; d-Chlorpheniramine maleate; (+)-Chlorpheniramine maleate; 2438-32-6; B10YD955QW; CHEBI:4465; Chlorpheniramine d-form maleate
Indication Rheumatoid arthritis [ICD11: FA20] Approved [1]
Structure
3D MOL is unavailable 2D MOL
Pharmaceutical Properties Molecular Weight 390.9 Topological Polar Surface Area 90.7
Heavy Atom Count 27 Rotatable Bond Count 7
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
Cross-matching ID
PubChem CID
5281070
ChEBI ID
CHEBI:4465
CAS Number
2438-32-6
TTD Drug ID
D05ZGQ
Formula
C20H23ClN2O4
Canonical SMILES
CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O
InChI
1S/C16H19ClN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t15-;/m0./s1
InChIKey
DBAKFASWICGISY-DASCVMRKSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Didesmethyl-chlorpheniramine DM005384
13646739
Oxidation - Demethylation 1 [2]
N-desmethyl-chlorpheniramine DM005385
46781155
Oxidation - Demethylation 1 [2]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR005710 Dexchlorpheniramine maleate Didesmethyl-chlorpheniramine Oxidation - Demethylation CYP2D6 [2]
MR005711 Dexchlorpheniramine maleate N-desmethyl-chlorpheniramine Oxidation - Demethylation CYP2D6 [2]
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 2D6 (CYP2D6) DME0009 Homo sapiens
CP2D6_HUMAN
1.14.14.1
[2]
References
1 Dexchlorpheniramine was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine. Br J Clin Pharmacol. 2002 May;53(5):519-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.